Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

News Daily News

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Michael O'Riordan

September 20, 2016

News Daily News

Coronary Calcium Goes Beyond CV Risk to Predict a Spate of Other Diseases

Shelley Wood

March 10, 2016

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Daily News

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

L.A. McKeown

May 11, 2015

News Daily News

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

Yael L. Maxwell

December 27, 2012

News Daily News

Meta-analysis Supports CTA’s Predictive Value

Caitlin E. Cox

June 08, 2011

Advertisement

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Coronary Calcium Goes Beyond CV Risk to Predict a Spate of Other Diseases

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Lilly Provides Update on Evacetrapib Phase 3 Trial

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

Meta-analysis Supports CTA’s Predictive Value

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content